He answers our questions about the IGNITE4 trial, which evaluated eravacycline vs meropenem for the treatment of intra-abdominal infections among acutely hospitalized patients.
In this podcast, Soontharee Congrete, MD, talks about her team's latest study that investigated whether lactic acid could help determine which patients with pulmonary embolism have a high risk for...
Tim Turnham, PhD, Executive Director of the Melanoma Research Foundation, discusses the USPSTF's recent decision to reverse its position that annual skin screenings are recommended for all adults.
Craig A. Dionne, PhD, CEO of GenSpera, describes some of the drawbacks associated with common cancer treatments. Many types of drug therapies, like antiangiogenics and immunotherapies, may only be effective...
Matthew Binnicker, PhD, answers our questions about choosing the right test for the right patient, summarizes best practices for managing patients with viral gastroenteritis, and more.
Susan Prockop, MD, discusses the risk of developing a tumor or lymphoma following a stem cell or organ transplant in patients with Epstein-Barr virus who have had a bone marrow transplant.